Stanford researchers make progress in predicting which patients will suffer heart problems from chemotherapy, and may have found a drug to mitigate them.
Retail prices at pharmacies may bear little relationship to the actual market prices of medications, and pharmacy benefit managers are part of the reason.
More than a third of patients who are prescribed statins fail to take them regularly, and they are dying at higher rates as a result.
Scientists have created an algorithm that works to generate and refine DNA sequences that are likely to code for antimicrobial proteins.
Patients who are taking the most common type of antidepressant may feel more pain when taking certain opioids, Stanford researchers have found.
Patients who undergo physical therapy soon after a pain diagnosis are less likely to use opioids in the long term, a Stanford-Duke study finds.
The U.S. Preventative Services Task Force encourages those who are at high risk of contracting HIV to take a daily pre-exposure drug.
Access and cost of insulin is affecting those who need it most, and without major improvements, millions will be without a treatment, a new study suggests.
Stanford researchers have shown in rats that pharmacologically active amounts of a fast-acting anesthetic drug could be released from nanoparticle "cages" in small, specified brain areas at which the scientists had aimed a beam of focused ultrasound. In principle, the same approach could work for many drugs with widely differing pharmacological actions and psychiatric applications, and even for some chemotherapeutic drugs used to combat cancer.
In the latest installment in the series Understanding AFib, Randall Stafford explains the different types of blood thinners.
This is the first in a series of three blog posts on aspirin for prevention. It clarifies the potential benefits and harms of aspirin use.
A team of researchers has updated and improved the equations that guide prescribing decisions for physicians in the U.S. regarding cardiovascular risk.
New Stanford Medicine research found that a compound called d-limonene has the potential to help head and neck cancer patients who suffer from dry mouth.
Stanford's David Ouyang sifted through more than a million texts to find out if clinicians inadvertently endorse brand-name medications over less expensive generic alternatives.
Ron Dror and colleagues used computer simulations and lab experiments to better understand G-protein-coupled receptors, which are critical to drug development. In the future, they hope to use this knowledge to design drugs with fewer side effects.
Stanford researchers set out to test a seminal theory of Parkinson’s disease and several related conditions. What they found is more complex than anyone had imagined.